Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases
Mitochondria are attractive cellular organelles which are so interesting in both basic and clinical research, especially after it was found that they were arisen as a bacterial intruder in ancient cells. Interestingly, even now, they are the focus of many investigations and their function and relevance to health and disease have remained open questions. More recently, research on mitochondria have turned out their potential application in medicine as a novel therapeutic intervention. The importance of this issue is highlighted when we know that mitochondrial dysfunction can be observed in a variety of diseases such as cardiovascular diseases, neurodegenerative diseases, ischemia, diabetes, renal failure, skeletal muscles disorders, liver diseases, burns, aging, and cancer progression. In other words, transplantation of viable mitochondria into the injured tissues would replace or augment damaged mitochondria, allowing the rescue of cells and restoration of the normal function. Therefore, mitochondrial transplantation would be revolutionary for the treatment of a variety of diseases in which conventional therapies have proved unsuccessful. Here, we describe pieces of evidence of mitochondrial transplantation, discuss and highlight the current and future directions to show why mitochondrial transplantation could be a master key for treatment of a variety of diseases or injuries.
KeywordsMitochondria dysfunction Reactive oxygen species Neurodegenerative diseases Heart failure Mitochondrial transplantation
Part of this study was supported by National Institute for Medical Research Development (Grant No. 962134).
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- Di Domenico F, Barone E, Perluigi M, Butterfield DA (2017) The triangle of death in Alzheimer’s disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics. Antioxid Redox Signal 26:364–387CrossRefPubMedGoogle Scholar
- Elliott R, Jiang X, Head J (2015) Mitochondria organelle transplantation: a potential cellular biotherapy for cancer. J Surg S(2):9Google Scholar
- Kanaan GN, Harper ME (2017) Cellular redox dysfunction in the development of cardiovascular diseases. Biochim Biophys Acta 2:30241–30244Google Scholar
- Kuck JL, Obiako BO, Gorodnya OM, Pastukh VM, Kua J, Simmons JD, Gillespie MN (2015) Mitochondrial DNA damage-associated molecular patterns mediate a feed-forward cycle of bacteria-induced vascular injury in perfused rat lungs. Am J Phys Lung Cell Mol Phys 308:1078–1085Google Scholar
- Kuwahara Y, Roudkenar MH, Suzuki M, Urushihara Y, Fukumoto M, Saito Y, Fukumoto M (2016) The involvement of mitochondrial membrane potential in cross-resistance between radiation and docetaxel. Int J Radiat Oncol Biol Phys 96:556–565. https://doi.org/10.1016/j.ijrobp.2016.07.002 CrossRefPubMedGoogle Scholar
- Ma S et al (2017) SIRT1 Activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice. Oxid Med Cell Longev 4602715:13Google Scholar
- Pacak CA et al (2015) Actin-dependent mitochondrial internalization in cardiomyocytes: evidence for rescue of mitochondrial function. Biology open:BIO201511478Google Scholar
- Preble JM, Kondo H, Levitsky S, McCully JD (2013) Quality control parameters for mitochondria transplant in cardiac tissue. Mol Biol 2:1008Google Scholar
- Preble J, Kondo H, Levitsky S, James D, McCully J (2014a) Quality control parameters for mitochondria transplant in cardiac tissue JSM Biochem. Mol Biol 2:1008Google Scholar
- Salimi A, Roudkenar MH, Sadeghi L, Mohseni A, Seydi E, Pirahmadi N, Pourahmad J (2015) Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria. Redox Biol 6:461–471. https://doi.org/10.1016/j.redox.2015.08.021 CrossRefPubMedPubMedCentralGoogle Scholar
- Salimi A, Roudkenar MH, Seydi E, Sadeghi L, Mohseni A, Pirahmadi N, Pourahmad J (2017) Chrysin as an anti-cancer agent exerts selective toxicity by directly inhibiting mitochondrial complex II and V in CLL B-lymphocytes. Cancer Invest 35:174–186. https://doi.org/10.1080/07357907.2016.1276187 CrossRefPubMedGoogle Scholar
- Schirone L et al (2017) A review of the molecular mechanisms underlying the development and progression of cardiac remodeling. Oxid Med Cell Longev 3920195:2Google Scholar
- Tymoczko JL, Berg JM, Stryer L (2011) Biochemistry: a short course. Macmillan, New YorkGoogle Scholar